Utilisation, effectiveness, and safety of immediate postpartum intrauterine device insertion: a systematic literature review.

contraceptive effectiveness intrauterine devices long-acting reversible contraception patient safety

Journal

BMJ sexual & reproductive health
ISSN: 2515-2009
Titre abrégé: BMJ Sex Reprod Health
Pays: England
ID NLM: 101715577

Informations de publication

Date de publication:
04 2023
Historique:
received: 03 05 2022
accepted: 25 10 2022
medline: 13 4 2023
pubmed: 6 1 2023
entrez: 5 1 2023
Statut: ppublish

Résumé

Intrauterine devices (IUDs) are highly effective contraception. IUDs inserted directly following delivery provide immediate birth control and may decrease unintended pregnancies, including short-interval pregnancies, thereby mitigating health risks and associated economic burden. This systematic literature review included published global data on the utilisation, effectiveness, and safety of postpartum intrauterine devices (PPIUDs) of any type. English language articles indexed in MEDLINE, Embase, and Cochrane from January 2010-October 2021 were included. 133 articles met the inclusion criteria (46% interventional studies; 54% observational; n=87 from lower-income countries; n=46 from higher-income countries). PPIUD use was low in higher-income countries (6/10 000 US deliveries in 2013-2016) and varied widely in lower-income countries (2%-46%). Across both higher- and lower-income countries, in most studies (79%), >80% of women with PPIUDs had an IUD in place by 3 months; at 6 and 12 months, 76% and 54% of included studies reported that >80% of women had an IUD in place; reason for discontinuation was infrequently reported. Pregnancies were rare (96 pregnancies across 12 191 women from 37 studies reporting data) and were generally unrelated to device failure, but rather occurred in women no longer using a PPIUD. Expulsions occurred mainly in the early outpatient period and ranged widely (within 3 months: 0-41%). Abnormal bleeding, infections, or perforations were rare. PPIUDs are safe and effective. Long-term follow-up data are limited. Future research elucidating reasons underlying lack of PPIUD use is warranted.

Sections du résumé

BACKGROUND
Intrauterine devices (IUDs) are highly effective contraception. IUDs inserted directly following delivery provide immediate birth control and may decrease unintended pregnancies, including short-interval pregnancies, thereby mitigating health risks and associated economic burden.
METHODS
This systematic literature review included published global data on the utilisation, effectiveness, and safety of postpartum intrauterine devices (PPIUDs) of any type. English language articles indexed in MEDLINE, Embase, and Cochrane from January 2010-October 2021 were included.
RESULTS
133 articles met the inclusion criteria (46% interventional studies; 54% observational; n=87 from lower-income countries; n=46 from higher-income countries). PPIUD use was low in higher-income countries (6/10 000 US deliveries in 2013-2016) and varied widely in lower-income countries (2%-46%). Across both higher- and lower-income countries, in most studies (79%), >80% of women with PPIUDs had an IUD in place by 3 months; at 6 and 12 months, 76% and 54% of included studies reported that >80% of women had an IUD in place; reason for discontinuation was infrequently reported. Pregnancies were rare (96 pregnancies across 12 191 women from 37 studies reporting data) and were generally unrelated to device failure, but rather occurred in women no longer using a PPIUD. Expulsions occurred mainly in the early outpatient period and ranged widely (within 3 months: 0-41%). Abnormal bleeding, infections, or perforations were rare.
CONCLUSIONS
PPIUDs are safe and effective. Long-term follow-up data are limited. Future research elucidating reasons underlying lack of PPIUD use is warranted.

Identifiants

pubmed: 36600467
pii: bmjsrh-2022-201579
doi: 10.1136/bmjsrh-2022-201579
pmc: PMC10176355
doi:

Types de publication

Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: EG-E reports personal fees from Xcenda LLC, during the conduct of the study. JL reports personal fees, non-financial support and other from Bayer US LLC, outside the submitted work. KRB, YW, NW, and FP are all employees of Bayer, which manufactures IUDs among its portfolio of products.

Références

Contraception. 2015 Mar;91(3):198-203
pubmed: 25499587
Am J Obstet Gynecol. 2017 Dec;217(6):665.e1-665.e8
pubmed: 28842126
Int J Reprod Med. 2016;2016:7695847
pubmed: 27631023
Int J Gynaecol Obstet. 2018 Sep;143 Suppl 1:28-32
pubmed: 30225870
Rev Bras Ginecol Obstet. 2019 Aug;41(8):485-492
pubmed: 31450255
Open Access J Contracept. 2020 Aug 21;11:91-102
pubmed: 32904608
Contraception. 2012 Aug;86(2):102-5
pubmed: 22264666
Obstet Gynecol. 2015 Jul;126(1):5-11
pubmed: 26241250
Perspect Sex Reprod Health. 2003 Mar-Apr;35(2):94-101
pubmed: 12729139
Am J Obstet Gynecol. 2017 Jul;217(1):51.e1-51.e7
pubmed: 28342716
Contraception. 2014 Jun;89(6):534-9
pubmed: 24457061
Cochrane Database Syst Rev. 2015 Jun 26;(6):CD003036
pubmed: 26115018
Eur J Contracept Reprod Health Care. 2017 Dec;22(6):424-428
pubmed: 29322856
Hawaii J Med Public Health. 2018 Mar;77(3):60-65
pubmed: 29541551
J Obstet Gynaecol India. 2018 Jun;68(3):208-213
pubmed: 29896001
Acta Obstet Gynecol Scand. 2020 May;99(5):598-607
pubmed: 31837002
Contraception. 2016 Apr;93(4):347-355
pubmed: 26738620
Int Perspect Sex Reprod Health. 2020 Dec 31;46:235-245
pubmed: 33544562
Am J Obstet Gynecol. 2018 Sep;219(3):235-241
pubmed: 30031750
J Obstet Gynaecol India. 2019 Oct;69(5):462-466
pubmed: 31598051
Contraception. 2019 Feb;99(2):94-97
pubmed: 30452904
Value Health. 2003 Mar-Apr;6(2):90-7
pubmed: 12641858
J Obstet Gynaecol India. 2015 Dec;65(6):386-8
pubmed: 26663997
Acta Obstet Gynecol Scand. 2021 Apr;100(4):596-603
pubmed: 33421091
Contraception. 2020 Jun;101(6):384-392
pubmed: 31935388
Glob Health Sci Pract. 2016 Jun 27;4(2):276-83
pubmed: 27353620
Eur J Contracept Reprod Health Care. 2020 Dec;25(6):439-444
pubmed: 33006501
Obstet Gynecol. 2017 Sep;130(3):609-615
pubmed: 28796678
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Int J Gynaecol Obstet. 2015 Aug;130(2):179-82
pubmed: 25957802
Indian J Med Res. 2012 Sep;136(3):432-5
pubmed: 23041736
Afr J Reprod Health. 2013 Jun;17(2):72-9
pubmed: 24069753
Mymensingh Med J. 2018 Jul;27(3):527-535
pubmed: 30141442
Int J Gynaecol Obstet. 2012 Jun;117(3):243-7
pubmed: 22445950
Int J Gynaecol Obstet. 2018 Sep;143 Suppl 1:38-42
pubmed: 30225875
J Pak Med Assoc. 2018 Apr;68(4):519-525
pubmed: 29808038
Int J Gynaecol Obstet. 2015 Jun;130 Suppl 2:S54-61
pubmed: 26115859
Int J Gynaecol Obstet. 2015 Aug;130(2):174-8
pubmed: 25975871
Glob Health Sci Pract. 2016 Aug 18;4 Suppl 2:S140-52
pubmed: 27540120
J Obstet Gynaecol India. 2018 Apr;68(2):129-135
pubmed: 29662283
J Obstet Gynaecol India. 2021 Apr;71(2):150-155
pubmed: 34149217
Acta Obstet Gynecol Scand. 2017 Sep;96(9):1144-1151
pubmed: 28590560
Acta Obstet Gynecol Scand. 2019 Nov;98(11):1378-1385
pubmed: 31001809
Am J Obstet Gynecol. 2012 Feb;206(2):127.e1-7
pubmed: 21963310
J Obstet Gynaecol India. 2017 Oct;67(5):324-329
pubmed: 28867882
Int J Gynaecol Obstet. 2012 Jan;116(1):31-4
pubmed: 22036512
Contraception. 2020 Dec;102(6):409-413
pubmed: 32918870
Contraception. 2016 Feb;93(2):178-83
pubmed: 26475368
Int J Gynaecol Obstet. 2018 Sep;143 Suppl 1:49-55
pubmed: 30225871
Contraception. 2011 Sep;84(3):244-8
pubmed: 21843688
N Engl J Med. 2012 May 24;366(21):1998-2007
pubmed: 22621627
J Family Med Prim Care. 2016 Oct-Dec;5(4):770-776
pubmed: 28348988
J Obstet Gynaecol India. 2021 Aug;71(4):430-436
pubmed: 34566304
Int J Gynaecol Obstet. 2018 Sep;143 Suppl 1:20-27
pubmed: 30225873
J Obstet Gynaecol India. 2017 Jun;67(3):202-207
pubmed: 28546668
Contraception. 2015 Dec;92(6):532-5
pubmed: 26408376
Int J Gynaecol Obstet. 2018 Sep;143 Suppl 1:33-37
pubmed: 30225877
JNMA J Nepal Med Assoc. 2020 Jan;58(221):1-5
pubmed: 32335630
Reprod Health. 2020 Mar 18;17(1):41
pubmed: 32183877
J Obstet Gynaecol India. 2016 Feb;66(1):35-41
pubmed: 26924905
Reprod Health. 2020 Oct 6;17(1):150
pubmed: 33023611
BMC Pregnancy Childbirth. 2015 Sep 02;15:202
pubmed: 26330364
Contraception. 2013 Feb;87(2):154-61
pubmed: 22959904
Cureus. 2020 Sep 25;12(9):e10647
pubmed: 33133817
Gates Open Res. 2018 Oct 10;2:38
pubmed: 30569036
J Gynecol Obstet Biol Reprod (Paris). 2013 Oct;42(6):585-90
pubmed: 23850420
J Obstet Gynaecol India. 2019 Aug;69(4):325-329
pubmed: 31391738
Sex Reprod Health Matters. 2021;29(2):1-16
pubmed: 34148520
Fertil Steril. 2015 Jan;103(1):131-7
pubmed: 25439838
Reprod Health. 2019 May 29;16(1):69
pubmed: 31142344
Am J Obstet Gynecol. 2020 Aug;223(2):177-188
pubmed: 32142826
J Obstet Gynaecol India. 2020 Apr;70(2):145-151
pubmed: 32255953
Glob Health Sci Pract. 2016 Mar 25;4(1):132-40
pubmed: 27016549
J Fam Plann Reprod Health Care. 2016 Jul;42(3):171-6
pubmed: 27030698
Int J Gynaecol Obstet. 2016 Nov;135(2):149-153
pubmed: 27527531
Contraception. 2020 Jun;101(6):399-404
pubmed: 32201097
Contraception. 2015 Apr;91(4):284-8
pubmed: 25553871
Contraception. 2011 Sep;84(3):240-3
pubmed: 21843687
J Coll Physicians Surg Pak. 2011 Sep;21(9):527-30
pubmed: 21914407
Am J Obstet Gynecol. 2017 Dec;217(6):674.e1-674.e8
pubmed: 28826801
Ultrasound Obstet Gynecol. 2015 Jul;46(1):104-8
pubmed: 25418016
Contracept Reprod Med. 2021 Feb 2;6(1):4
pubmed: 33526103
BMJ Sex Reprod Health. 2021 Jul;47(3):173-178
pubmed: 32938708
Int J Gynaecol Obstet. 2022 Apr;157(1):67-75
pubmed: 34197636
Contraception. 2013 Feb;87(2):149-53
pubmed: 22878145
BMJ Sex Reprod Health. 2019 Aug 7;:
pubmed: 31391215
J Clin Diagn Res. 2016 Jan;10(1):LC01-4
pubmed: 26894092
Contraception. 2019 Apr;99(4):212-216
pubmed: 30576637
BMC Pregnancy Childbirth. 2020 Oct 27;20(1):650
pubmed: 33109097
J Clin Diagn Res. 2014 Sep;8(9):OC01-4
pubmed: 25386484
Contracept X. 2020 Oct 09;2:100040
pubmed: 33196037
Contraception. 2020 Mar;101(3):153-158
pubmed: 31927027
Womens Health Issues. 2019 Nov - Dec;29(6):465-470
pubmed: 31495642
Rev Gaucha Enferm. 2021 Feb 08;42:e20200015
pubmed: 33566948
Contraception. 2022 Jan;105:55-60
pubmed: 34529951
East Afr Med J. 2014 Dec;91(12):449-56
pubmed: 26859013
J Obstet Gynaecol India. 2014 Oct;64(5):337-43
pubmed: 25368457
Womens Health Issues. 2021 Mar-Apr;31(2):164-170
pubmed: 33323329
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
Aust N Z J Obstet Gynaecol. 2015 Jun;55(3):279-83
pubmed: 26053465
Contracept Reprod Med. 2021 Mar 2;6(1):7
pubmed: 33648587
J Obstet Gynaecol India. 2019 Aug;69(4):344-349
pubmed: 31391742
Eur J Contracept Reprod Health Care. 2016 Oct;21(5):356-60
pubmed: 27367825
J Fam Plann Reprod Health Care. 2017 Jul;43(3):186-194
pubmed: 27207850
Rev Panam Salud Publica. 2011 Feb;29(2):103-7
pubmed: 21437367
J Obstet Gynaecol India. 2020 Feb;70(1):64-68
pubmed: 32030008
BMJ Open Qual. 2021 Jul;10(Suppl 1):
pubmed: 34344746
Eur J Contracept Reprod Health Care. 2020 Dec;25(6):465-473
pubmed: 32990066
BMC Res Notes. 2020 Apr 10;13(1):204
pubmed: 32276669
Contraception. 2018 Apr 17;:
pubmed: 29678365
Obstet Gynecol. 2010 Nov;116(5):1079-87
pubmed: 20966692
Contraception. 2019 Aug;100(2):101-105
pubmed: 31108053
Matern Child Health J. 2021 Sep;25(9):1361-1368
pubmed: 34109490
J Obstet Gynaecol India. 2014 Oct;64(5):349-53
pubmed: 25368459
Reprod Health. 2014 Apr 23;11:32
pubmed: 24755312
Eur J Contracept Reprod Health Care. 2015 Feb;20(1):4-18
pubmed: 25397890
Cureus. 2019 Sep 13;11(9):e5646
pubmed: 31700748
Reprod Health. 2017 Mar 14;14(1):42
pubmed: 28292333
Contraception. 2018 Sep;98(3):215-219
pubmed: 29750926
Heliyon. 2021 Jan 21;7(1):e06034
pubmed: 33521367
Contraception. 2018 Mar;97(3):215-218
pubmed: 29128372
J Turk Ger Gynecol Assoc. 2020 Jun 10;21(3):143-149
pubmed: 32517434
Contraception. 2014 Jun;89(6):528-33
pubmed: 24565735
Am J Obstet Gynecol. 2018 Aug;219(2):183.e1-183.e9
pubmed: 29870737
Am J Obstet Gynecol. 2019 Jan;220(1):B2-B18
pubmed: 30579872
Eur J Contracept Reprod Health Care. 2018 Aug;23(4):255-259
pubmed: 30273057
Lancet Glob Health. 2020 Sep;8(9):e1152-e1161
pubmed: 32710833
Hosp Pediatr. 2021 Jul;11(7):764-770
pubmed: 34112700

Auteurs

Kristina Rosa Bolling (K)

Bayer Healthcare, Whippany, New Jersey, USA.

Yesmean Wahdan (Y)

Bayer Healthcare, Whippany, New Jersey, USA.

Neal Warnock (N)

Bayer Healthcare, Whippany, New Jersey, USA.

Jason Lott (J)

Bayer Healthcare, Whippany, New Jersey, USA.

Juliane Schoendorf (J)

Bayer Oy, Espoo, Uusimaa, Finland.

Federica Pisa (F)

Bayer Schering Pharma AG, Berlin, Germany.

Evelyn Gomez-Espinosa (E)

Xcenda LLC, Carrollton, Texas, USA.

Kristin Kistler (K)

Xcenda LLC, Carrollton, Texas, USA kristin.kistler@xcenda.com.

Brett Maiese (B)

Xcenda LLC, Carrollton, Texas, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH